2017 Annual Meeting

Ohio-ACC 27th Annual Meeting & 6th Annual Richard Lewis Memorial Lecture
October 14, 2017  |  Hilton Columbus at Easton, Columbus, OH

Meeting Brochure  |  Syllabus/Disclosures  |  Posters

For slide handouts, please utilize the “Agenda” tab. You can watch some great attendee interviews on YouTube!

Special thanks to Dr. Robert Mosteller for helping with the photography.

Photos

 

 

Agenda

Saturday, October 14

7:00-7:55 a.m.
Registration, Exhibits, Posters, and Continental Breakfast

7:55-8:00 a.m.
Welcoming Remarks
Laxmi S. Mehta, MD, FACC

8:00-8:45 a.m.
Issues from the ACC: What Is Impacting CV Providers in 2017
C. Michael Valentine, MD, FACC
handout  |  CV Summit

8:45-9:30 a.m.
Strategic Coding in the Era of MACRA: Impact of Risk Scoring and Attribution
Linda Gates-Striby CCS-P, ACS-CA
handout

9:30-10:15 a.m.
Break, Exhibits, Poster Competition

10:15-11:00 a.m.
Emerging Technologies in the Cath & EP Labs
Mauricio Arruda, MD (EP Lab) – handout
Ankur Kalra, MD, FACC (Cath Lab) – handout

11:00-11:45 a.m.
DAPT & NOACs: EP, Interventional & Pharmacy Aspects
Ernest L. Mazzaferri Jr., MD, FACC – (Interventional) – handout
Mike Boyd, PharmD, BCPS – (Pharmacy) – handout
John Rickard, MD, MPH – (EP) – handout

11:45 a.m. – 12:30 p.m.
Lunch Break, Exhibits, Posters
Networking Round Tables: Look for a table that interests you!

12:30-1:00 p.m.
Fellow in Training Oral Competition
Katherine Dodd, DO, Development of Late Right-Sided Heart Failure Predicts 1-Year Mortality Post-LVAD Implantation – OSU
Avirup Guha, MD, Trends in Hospitalization of Patients with Acute Coronary Syndrome and Concurrent Amyloidosis – OSU

1:00-2:00 p.m.
6th Annual Richard P. Lewis Memorial Lecture
Acute Aortic Syndromes:  State of the Art
Kim A. Eagle, MD, MACC
handout

2:00-2:15 p.m.
Announcement of Poster Winners and Oral Competition Winners

 

Posters

Poster Submission Listing

Poster Competition Winners

Fellow in Training Oral Presentation

First place – Katherine Dodd, DO, OSUMC

Second place – Avi Guha, MD, OSUMC

Fellow in Training Clinical Research Posters 1st/2nd year

First place – Peter Hu, MD, CCF

Second place – Andrew Noll, MD, CCF

Fellow in Training Clinical Research Posters 3rd year & Advanced Fellowship

First place – Adam Powell, MD, CCHMC

Second place – Colleen Pater, MD, CCHMC

Fellow in Training Case Report Poster Winners

1st year – Kelly Laipply, MD, UC

2nd year – Cameron Lambert, MD, CCF

3rd year/advanced fellowship – Laura D’Addese, MD, CCF Pediatric Cardiology

CV Team Members (RN, NP, CNS, PA, PharmD) Case Report Poster Winner

First place – Julie Mease, NP, OSUMC

Resident Case Report Poster Winner

First place – Daniel Pinkas, DO, OSUMC

 

CME/CNE

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Cardiology Foundation and Ohio Chapter of the American College of Cardiology. The American College of Cardiology Foundation is accredited by the ACCME to provide continuing medical education for physicians.

The ACCF designates this live educational activity for a maximum of 5.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

Nurses

American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

The ACCF designates this live educational activity for a maximum of this 5.25 CNE contact hours  (0.75 CNE Pharmacotherapeutic contact hours). Each attendee should only claim credits commensurate with the extent of their participation in the activity.

While offering credits noted above, the course is not intended to provide extensive training or certification in this field.

ATTENTION Nurses who are in need of Category A credit, please visit: http://www.netce.com/3271/Catalog_OH14.pdf. Take a look at the Ohio Nurse Practice Act module on pages 3-11 and then scroll to page 91.

Statement of Need
The cardiac care team is increasingly asked to develop systems of care, the methods for which are not necessarily part of the traditional medical training, and to perform better, faster, more efficiently and at a lower cost. Identified learning needs for 2017 Ohio CV practitioners include updates in payment systems (i.e. MACRA), emerging cath and EP technologies, dual antiplatelet therapy & novel anticoagulants, and acute aortic syndromes.

Overall Goal
The overall goal of this activity is to increase learner competence by discovering strategies to anticipate research-driven changes in practice, to enhance professional growth, and to demonstrate efficacy in team based patient care practice as new clinical approaches and technologies change. The Ohio Chapter-ACC Annual Meeting will include education that provides needs-based learning covering a thorough overview of health care legislation and regulation, emerging cath and EP technologies, dual antiplatelet therapy & novel anticoagulants, and acute aortic syndromes.

Learner Objectives
Upon completion of this program, participants should be able to:

  • Identify tools, resources, and regulations that impact the practice environment.
  • Apply innovative technology to improve care of patient/population and management of cardiovascular disease.
  • Analyze the clinical implications of polypharmacy and cardiovascular interventions in the patient with cardiovascular disease.
  • Interpret cases of acute aortic syndromes and appropriate treatment.

Target Audience
Adult Cardiologists, Pediatric Cardiologists, Cardiothoracic Surgeons, Cardiology Fellows-in-Training, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, Pharmacists

Disclosure Policy
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC), the American College of Cardiology Foundation (ACCF) must ensure balance, independence, objectivity and scientific rigor in all of their directly provided or jointly provided/co-provided educational activities. Planners, presenters, and other contributors, in a position to control the content are required to disclose to the audience all relevant financial relationships he/she and/or his/her spouse or domestic partner may have, occurring within the past 12 months, with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. When an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, the contributor should disclose that the product is not labeled for the use under discussion or that the product is still investigational.

ACCF is committed to providing its learners with high-quality activities and materials that promote improvements and quality in health care and not a specific proprietary business or commercial interest. The intent of this disclosure is not to prevent participation in educational activities by persons with a financial or other relationship, but rather to provide learners with information on which they can make their own determination whether financial interests or relationships may influence the education activity.

ACCF assesses conflicts of interest (COI) with its faculty, planners, managers, staff and other individuals who are in a position to control the content of CME/CNE activities. All relevant potential conflicts of interest that are identified are thoroughly vetted through a process that includes course directors and appropriate peer review by education committee chairs/members, for fair balance, scientific objectivity and validity, and patient care and safety recommendations.

Exhibitors

Appreciation is expressed to the following companies for providing educational grants:
Boston Scientific
Chiesi USA, Inc.

Appreciation is expressed to the following company for its Silver Sponsorship:
Portola Pharmaceuticals

Appreciation is expressed to the following companies for exhibiting at this conference:
Abbott
Ambry Genetics
American College of Cardiology
Amgen
AstraZeneca
AtriCure, Inc.
Boehringer Ingelheim Pharmaceuticals
Boston Scientific
Chiesi USA, Inc.
CryoLife
Gilead Sciences (2)
Janssen
Kastle Therapeutics
Kowa Pharmaceuticals
Lantheus Medical Imaging
LifeWatch Services, Inc.
Lundbeck
Medtronic
Novartis Pharmaceuticals Inc.
Otsuka America
Pfizer
sanofi
Spectranetics
ZOLL